Prudential Financial
AUPH icon

Prudential Financial’s Aurinia Pharmaceuticals AUPH Stock Holding History

Prudential Financial’s Portfolio AUPH Stock Details AUPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$9.88M Sell
582,345
-8,265
-1% -$132K 0.01% 700
2026
Q1 		$8.75M Buy
590,610
+218,050
+59% +$3.19M 0.01% 675
2025
Q4 		$5.94M Buy
372,560
+274,875
+281% +$3.9M 0.01% 841
2025
Q3 		$1.08M Sell
97,685
-66,545
-41% -$727K ﹤0.01% 1624
2025
Q2 		$1.39M Buy
164,230
+4,200
+3% +$33.7K ﹤0.01% 1540
2025
Q1 		$1.29M Buy
+160,030
New +$1.3M ﹤0.01% 1477
2023
Q3 		– Sell
-241,740
Closed -$2.34M – 2601
2023
Q2 		$2.34M Buy
+241,740
New +$2.51M ﹤0.01% 1313

Other funds holding AUPH

TCM
Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.59B AUM 234.06% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Prudential Financial's AUPH Position: Q2 2026 in Review

Prudential Financial reduced its Aurinia Pharmaceuticals (AUPH) stake by 1.4% in Q2 2026, selling an estimated $132K and leaving 582,345 shares worth $9.88M. The position accounts for 0.01% of the portfolio, ranked #700.

Prudential Financial first reported a position in AUPH in Q2 2023 and has held it in 7 quarters since. 281 funds tracked by Wall St. Rank hold AUPH as of Q2 2026.

  • Prudential Financial held 582,345 shares of Aurinia Pharmaceuticals worth $9.88M as of Q2 2026.
  • Prudential Financial sold 8,265 Aurinia Pharmaceuticals shares in Q2 2026, an estimated $132K.
  • Aurinia Pharmaceuticals made up 0.01% of Prudential Financial's portfolio in Q2 2026, its #700 holding.
  • Prudential Financial first reported a position in Aurinia Pharmaceuticals in Q2 2023 and has held it in 7 quarters since.
  • 281 funds tracked by Wall St. Rank held Aurinia Pharmaceuticals as of Q2 2026.

Based on Prudential Financial's 13F filing for Q2 2026, filed 12 Aug 2026.